Kalcioglu, MTKuku, IKaya, EOncel, SAydogdu, I2024-08-042024-08-0420031120-009Xhttps://doi.org/10.1179/joc.2003.15.3.290https://hdl.handle.net/11616/93553Vincristine sulfate is a chemotherapeutic agent used in different cancer therapies. It is also the first choice of treatment for peripheral T-cell lymphoma with cyclophosphamide and adriamycin. Sudden hearing loss during vincristine therapy is a very rare event. This is a case of a 16-year old girl who developed sudden bilateral hearing loss related to vincristine therapy.eninfo:eu-repo/semantics/closedAccessvincristinehearing losstoxicityperipheral T-cell lymphomaArticle1532902921286855810.1179/joc.2003.15.3.2902-s2.0-0038345540Q3WOS:000184062100014Q3